Lp(a): a genetic cause of clinical FH in children.

Abstract readEditorialComment

In one paragraph

Article in European heart journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it

0cells of the map it votes in

6citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes.Heliyon · 2024
Article
Lipoprotein(a) in Children and Adolescents: Risk or Causal Factor for Cardiovascular Disease? A Narrative Review.International journal of molecular sciences · 2024
Review
Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex.Pediatric research · 2024
Article
High lipoprotein(a): Actionable strategies for risk assessment and mitigation.American journal of preventive cardiology · 2024
Review
2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents.Archives of medical science : AMS · 2024
Article
Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents.Biomedicines · 2023
Review

4 · The record

Corrections and comments

Comment on
Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study.2023

5 · Who and what money

Authors and funding

2 authors.

Maurizio R AvernaDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Università degli Studi di Palermo, Via del Vespro 129, 90127 Palermo, Italy.ORCID 0000-0003-3558-9209

Angelo B CefalùDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Università degli Studi di Palermo, Via del Vespro 129, 90127 Palermo, Italy.ORCID 0000-0003-1259-8284

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hyperlipoproteinemia Type IILipoprotein(a)ChildCholesterol, LDLCross-Sectional StudiesHumansCholesterol, LDLLipoprotein(a)

Identifiers

PMID36583254

DOI10.1093/eurheartj/ehac789

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.